[NH2:1][C:2]([CH3:6])([CH3:5])[CH2:3][OH:4].[H-].[Na+].[CH:9]([N:12]1[C:16]([C:17]2[N:18]=[C:19]3[C:25]4[CH:26]=[CH:27][C:28]([C:30](OC)=O)=[CH:29][C:24]=4[O:23][CH2:22][CH2:21][N:20]3[CH:34]=2)=[N:15][CH:14]=[N:13]1)([CH3:11])[CH3:10].C(Cl)Cl.S(Cl)(Cl)=O>O1CCCC1.C1COCC1.CN(C=O)C>[CH3:5][C:2]1([CH3:6])[CH2:3][O:4][C:30]([C:28]2[CH:27]=[CH:26][C:25]3[C:19]4[N:20]([CH:34]=[C:17]([C:16]5[N:12]([CH:9]([CH3:11])[CH3:10])[N:13]=[CH:14][N:15]=5)[N:18]=4)[CH2:21][CH2:22][O:23][C:24]=3[CH:29]=2)=[N:1]12-Amino-2-methyl-1-propanol (0.20 g, 2.3 mmol) was dissolved in tetrahydrofuran (2.2 mL) and NaH (60% in mineral oil, 0.0942 g) was added. The resulting mixture was stirred for 1 h at room temp. To this mixture was added methyl 2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-9-carboxylate 184 (0.40 g, 1.1 mmol) in THF/DMF (1:1, 10 mL). The entire reaction mixture was stirred at ambient temperature overnight. The reaction was quenched with water and diluted with EtOAc. Extracted, dried over MgSO4, filtered and concentrated. Dissolved in Methylene chloride (10 mL, 200 mmol) and cooled to at 0° C. and treated with thionyl chloride (0.314 mL, 4.30 mmol) dropwise. Following the addition, the reaction was warmed to room temp and stirred for 3 h. Concentrated in vacuo and purified by reverse phase HPLC to provide 199 (209 mg, 48% yield). LC/MS (ESI+): m/z 393 (M+H). 1H NMR (400 MHz, DMSO) δ 8.47 (d, J=8.4, 1H), 7.99 (s, 1H), 7.92 (d, J=3.5, 1H), 7.59 (dd, J=8.4, 1.6, 1H), 7.45 (d, J=1.6, 1H), 5.85 (dt, J=13.2, 6.6, 1H), 4.55 (dd, J=10.6, 6.4, 4H), 4.12 (s, 2H), 1.49 (d, J=6.6, 6H), 1.30 (s, 6H)
Wird geladen…